greenway medical technologie
(GWAY:New York)
greenway medical technologie (GWAY) Key Developments
Greenway Medical Technologies, Inc. announced that PrimeMOBILE(TM), Greenway's mobile access solution for PrimeSUITE(R) electronic health record customers, is now Microsoft-certified and available for download at the Windows 8 Store. The Windows 8 version of the PrimeMOBILE app joins existing versions for iPad, iPhone, Android Phone, Android Tablet and Windows Phone. By extending PrimeMOBILE to the new Windows 8 platform, Greenway has made PrimeSUITE mobile-accessible from every leading smartphone and tablet platform a healthcare provider may choose to support. Greenway's PrimeMOBILE app for Windows 8 provides complete remote access to patient data housed in Greenway's EHR solution, enabling providers to securely view patient history and problem lists, progress notes and appointment schedules that encompass a provider's entire patient population. All versions of the PrimeMOBILE app gives physicians and other clinicians access to the most common functionality of the Greenway PrimeSUITE EHR, enabling them to retrieve important care data from virtually any location.
West Georgia Technical College has formed its newest partnership with Greenway Medical Technologies, Inc. It has teamed up with the College to provide Project Management Professional training classes to the company's project managers all over the country via interactive distance learning. The classes piloted in early April with nine students and include a series of five interactive eight-hour classes held on Saturdays for a total of 40 training hours. At the conclusion of the training, students receive their Project Management Professional (PMP) credential which is the only industry-recognized credential for project managers. In addition to the Project Management training, Greenway has agreed to provide the West Georgia Technical College Health Information Technology Program access to its PrimeSUITE software. The software will provide students with additional hands-on experience and the opportunity to train on job functions available in a traditional healthcare setting.
Greenway Medical Technologies, Inc. announced unaudited earnings results for the third quarter and nine months ended March 31, 2013. For the quarter, the company reported revenue of $33,823,000 compared to $32,865,000 for the same period last year. Operating loss was $2,792,000 compared to operating profit of $2,212,000 for the same period last year. Loss before provision for income taxes was $2,770,000 compared to income before provision for income taxes of $2,327,000 for the same period last year. Loss available to common shareholders was $608,000 or $0.02 per diluted share compared to income available to common shareholders of $1,379,000 or $0.06 per diluted share for the same period last year. Non-GAAP adjusted EBITDA was $588,000 compared to $3,974,000 for the same period last year. Non-GAAP adjusted net income was $409,000, or $0.01 per diluted share compared to $1,813,000 or $0.08 per diluted share for the same period last year. For the nine months, the company reported revenue of $99,318,000 compared to $87,638,000 for the same period last year. Operating loss was $4,825,000 compared to operating profit of $1,313,000 for the same period last year. Loss before provision for income taxes was $4,571,000 compared to income before provision for income taxes of $1,333,000 for the same period last year. Loss available to common shareholders was $1,585,000 or $0.05 per diluted share compared to income available to common shareholders of $29,100,000 or $1.89 per diluted share for the same period last year. Net cash provided by operating activities was $1,367,000 compared to $4,853,000 for the same period last year. Purchases of property and equipment were $7,837,000 compared to $6,250,000 for the same period last year. Acquisition of business and developed technology was $6,750,000 compared to $3,000,000 for the same period last year. Non-GAAP adjusted EBITDA was $4,484,000 compared to $6,207,000 for the same period last year. Non-GAAP adjusted net income was $1,251,000, or $0.04 per diluted share compared to $2,327,000 or $0.14 per diluted share for the same period last year. Adjusted EBITDA was $4.5 million as compared to $6.2 million for the same period last year.
Greenway Medical Technologies, Inc. revises earnings guidance for the fiscal year ending June 30, 2013. For the fiscal year ending June 30, 2013, the company expects revenue in the range of $132.0 million to $134.0 million, operating loss in the range of $7.0 million to $6.0 million, GAAP net loss of $3.7 million to $3.2 million, GAAP LPS of $0.13 to $0.11, adjusted EBITDA in the range of $5.8 million to $6.8 million, adjusted EBITDA margin will be 4.4% to 5.1%. The company expects gross profit of $68.0 million to $70.0 million, which means the range for gross margin is 51.5% to 52.2%.
Availity and Greenway Medical Technologies have joined in a project with Florida Blue, to enable physicians to exchange clinical and patient care summaries with the health plan through electronic health records (EHR) software, which then makes patient-specific clinical information accessible at the point of care. The companies are working together to foster collaborative coordinated care for all Florida residents. Delivering patient history and care reminders within the clinical workflow enables physicians and other clinicians to make better-informed care decisions by helping them to understand a patient's history; eliminate duplicate or unnecessary services; and identify other treating providers. As part of the project, physicians using the Greenway PrimeSUITE EHR will see up to two years of patient care history sourced from Florida Blue, presented in the EHR workflow by way of integration with Availity's patient care summary and encounter summary. Proactively presenting this information gives physicians a more holistic view of the patient's medical history, at an opportune time in the patient encounter. Additionally, physicians can automate the exchange of important clinical data back to the health plan for quality improvement reporting. Two-way integration at the EHR level reduces phone, fax and paper exchanges between providers and health plans, while simultaneously improving care and reducing costs.
| Recently Viewed | |||
| GWAY:US | $12.02 USD | +0.24 | |
| Company | Last | Change |
| Epic Corp/United States | $0.07 USD | -0.01 |
| Healthways Inc | $14.12 USD | +0.07 |
| Vemics Inc | $0.02 USD | -0.0027 |
| Quality Systems Inc | $17.92 USD | -0.67 |
| WebMD Health Corp | $28.57 USD | +0.30 |
| View Industry Companies | ||
Industry Analysis
GWAY
Industry Average
| Valuation | GWAY | Industry Range |
| Price/Earnings | 100.0x |
|
| Price/Sales | 2.6x |
|
| Price/Book | 3.4x |
|
| Price/Cash Flow | 576.7x |
|
| TEV/Sales | 2.5x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact GREENWAY MEDICAL TECHNOLOGIE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








